The present invention relates generally to the delivery of drugs, particularly to systems for subcutaneous injection/aspiration for drug delivery providing controlled metering and automatic delivery of a defined unit of a subcutaneous drug injection. In particular, the present invention provides a means and method of calculating, controlling, and monitoring fluid injections from a hypodermic needle.
Injection devices and systems are known in the medical arts, for use in delivery or a prescribed medication that are used for therapeutic and cosmetic purposes. Several systems have been developed for the administration of such injectable agents used to treat any of a number of conditions including but not limited to a cosmetic condition (i.e., wrinkles, sagging skin), pain (i.e., migraine), neurologic disorders (i.e., idiopathic neuropathy), endocrine condition, metabolic condition (i.e., diabetes), neuromuscular disorder (i.e., cervical dystonia, blepharospasm), inflammation (i.e., arthritis, psoriasis), vascular disorder (i.e., varicose veins, rosacea), cancer, infection, etc. Injectable agents can include but not be limited to neurotoxins, subcutaneous volume enhancers (dermal fillers), insulin, antibiotics, hormones, chemotherapeutic, or biological agents. Often certain procedures require a series of injections of varying amounts to be injected into the patient. Determining the amount of each injection and monitoring the amount of fluid injected can be cumbersome for a medical professional. Additionally, patient discomfort can result if the medicament is injected at a high rate. Conversely, if the flow rate for each injection is too low, the overall procedure can be elongated leading to patient discomfort and wasted time for the medical professional. Accordingly, there exists a need for a system for providing a controlled series of precise injections at an appropriate rate along with the ability to automatically calculate the appropriate volume for each injection to provide the desired number of units of medicament. Additionally, there exists a need for a system that tracks the amount of medicament injected during a series of injections along with the placement of the injections.
In light of the foregoing, the present invention provides a device and method that enables a practitioner to administer a precise standardized unit dose of a drug. The present invention also provides a method and apparatus for recording the location of injection on an anatomic pictorial record that can be recorded, stored and printed. The present invention further provides a method and apparatus for calculating and generating a standardized unit drug dose from a reconstituted (or diluted) drug that can then be used as a standardized dose unit between different drugs, providing a means of recording the injection related to specific unit dose on an anatomic pictorial record.
According to one aspect, the present invention provides an apparatus for providing an injection. The apparatus includes a fluid reservoir for retaining a volume of medicament that includes a number of units of medicament in a volume of diluent and a fluid controller for controlling the flow of fluid from the fluid reservoir. A needle is in fluid communication with the fluid reservoir for injecting the medicament subcutaneously or intramuscularly into the patient. The apparatus may optionally include a detector configured to detect a characteristic indicative of the fluid pressure of the fluid in the needle. The apparatus also includes an actuator for selectively actuating the fluid controller to provide a dose of medicament from the fluid reservoir. The fluid controller may be configured to to calculate the volume of fluid in the fluid reservoir required to provide a dose having a desired number of units of medicament for an injection. Additionally, the apparatus may include an input device for inputting information regarding the desired number of units in the dose.
According to another aspect, the invention provides an electric motor for driving a drive element connected with a fluid reservoir to expel fluid from a reservoir. Optionally, the fluid reservoir comprises a syringe having a barrel and a plunger slidable within the barrel. The fluid controller may be configured to engage the plunger of the syringe.
According to another aspect, the present invention comprises an apparatus for providing an injection comprising a fluid controller for providing a dose of medicament having a desired number of units of medicament, wherein the apparatus includes actuator in the form of a manually actuable button for providing control signals to the fluid controller.
According to a further aspect, the present invention provides a drug delivery system that includes a fluid controller having a processor operable to track the number of units of medicament dispensed during a procedure based on the number of times an actuator is actuated and information regarding the number of units injected upon each actuation of the actuator.
According to yet another aspect, the present invention provides a drug delivery system having a visual display for displaying a portion of the anatomy into which a needle provides a series of injections. Optionally, the display may provide a record keeping interface for indicating the anatomical location of each of the series of injections. Additionally, the record keeping interface may indicate the number of units injected at each anatomical location.
According to a further aspect, the present invention provides a drug delivery system having a fluid controller that comprises an electronic controller wherein the controller is configured to compare the number of units injected during a series of injections with the number of units indicated during a record keeping interface.
According to another aspect, the present invention provides a drug delivery system having a fluid controller and a fluid pressure sensor in line with a needle for detecting a characteristic indicative of the fluid pressure in the needle.
According to a further aspect, the present invention provides a method for using a fluid control system to automatically dispense fluid to a hollow needle for a series of injections. The method includes the step of preparing a volume of medicament by mixing a volume of diluent in a container having a number of units of medicament and providing a fluid reservoir having a volume of medicament from the container. Data is input into the fluid control system regarding the volume of diluent in the container and the number of units of medicament in the container. The fluid control system automatically calculates a unit volume, wherein the unit volume is the volume of fluid in the fluid reservoir required to dispense a unit of medicament based on the step of inputting data. The number of units to be dispensed during an injection is selected. The fluid control system automatically calculates the injection volume, wherein the injection volume is the volume of fluid in the fluid reservoir required to dispense the select number of units based on the calculated unit volume. An actuator is actuated, wherein in response to the step of actuating the fluid control system expels the calculated injection volume from the fluid reservoir. The steps of selecting and actuating may be repeated a plurality of times. The method may also include the step of tracking the total number of units dispensed during the steps of selecting and actuating to determine the total number of units dispensed during a procedure.
According to another aspect, the present invention provides a method for automatically dispensing fluid to a needle and the method includes the step of providing a visual display for displaying a portion of the anatomy into which a series of injections are provided and creating an injection map by identifying the location of each injection and the number of units injected at each location. The location and number of units may be identified on the portion of the anatomy displayed on the visual display.
According to a further aspect, the present invention provides a method for automatically dispensing fluid to a needle and the method comprises the step of calculating the difference between the total number of units dispensed during the procedure and the total number of units identified for each injection identified during the creation of an injection map.
According to yet another aspect, the present invention provides a method for automatically dispensing fluid to a needle and the method includes the step of calculating the number of units of medicament in a fluid reservoir; and re-calculating the number of units of medicament remaining in the fluid reservoir after each step of actuating an actuator to dispense fluid from the reservoir.
According to a further aspect, the present invention provides an apparatus for providing an injection from a fluid reservoir. The fluid reservoir contains a volume of medicament that includes a number of units of medicament in a volume of diluent. A fluid controller controls the flow of fluid from the fluid reservoir. A needle is in fluid communication with the fluid reservoir for injecting the medicament into the patient. An actuator is provided for selectively actuating the fluid controller to provide a dose of medicament from the fluid reservoir. The fluid controller may be operable to calculate the volume of fluid in the fluid reservoir required to provide a dose having a desired number of units of medicament for an injection. The apparatus may also include an input device for inputting information regarding the desired number of units in the dose. Additionally, the input device may include a visual display screen for displaying a record keeping interface for indicating the anatomical location of each of the series of injections.
According to yet another aspect, the present invention provides an apparatus for providing an injection and the system may include a display providing a record keeping interface that indicates the number of units injected at each of a series of anatomical locations.
According to a further aspect, the present invention provides an apparatus for providing an injection that includes a fluid controller. The fluid controller may include a processor operable to track the number of units dispensed during a procedure based on the number of times an actuator is actuated and information regarding the number of units injected upon each actuation of the actuator. Optionally, the processor may be configured to compare the number of units injected during the series of injections with the number of units indicated in the record keeping interface.
The foregoing summary and the following detailed description of the preferred embodiments of the present invention will be best understood when read in conjunction with the appended drawings, in which:
Referring now to the drawings, in general and to
Automated Fluid Delivery System
The system 10 includes a fluid delivery assembly 20 for providing a controlled flow of medication to an injection needle 120. The fluid delivery system is an automated system and in the present instance is a computer controlled fluid delivery system referred to as a drive unit 20.
Referring to
As shown in
The drive unit 20 includes a drive element for displacing the plunger 94 in the cradle 30 relative to the barrel 92. The drive element can be any of a variety of linearly displaceable elements that can be accurately controlled. For instance, the drive element may include a drive screw, wherein rotation of the screw drives the plunger forwardly. In the present instance, the drive unit 20 includes a drive block 50 that engages the rearward end of the plunger 94. The drive unit controls the forward movement of the drive block 50 to control the flow of fluid from the syringe 90 to the needle 120. In particular, the drive block 50 is axially displaceable within the plunger slot 34 to drive the plunger relative to the barrel. Specifically, the drive unit 50 controls the advancement of the drive block 20 to advance the plunger to eject fluid from the syringe barrel 92. Similarly, the drive unit controls retraction of the drive block 50 (i.e. axial displacement in a direction opposite of the advancement) to withdraw the plunger from the barrel to aspirate the syringe. The drive unit 50 may further includes a retention element for providing a releasable connection between the plunger 94 and the drive block 50. For example, the drive unit may include a plurality of resilient fingers that engage the thumb pad of the plunger to connect the plunger with the drive block 50.
The drive unit 20 includes an electronic controller, such as a microprocessor, for controlling the operation of the drive unit in response to signals received from the user. The electronic controller controls the drive mechanism that drives the drive block to provide an injection. For instance, the drive mechanism may include an armature connected with the drive block 50. The drive unit may control an electric motor that drives the armature to drive the drive block.
The drive unit 20 may provide a variety of input mechanisms for the medical professional to provide input signals for controlling the operation of the drive unit. For instance, the drive unit may include one or more of a variety of input devices, including, but not limited to: manually actuable buttons, a keyboard, a mouse, a foot pedal, or a touch screen. The system also includes a display 70 so that the user can monitor the progress of the medical procedure as well as review information regarding the procedure. In the present instance, the display is a touch screen display 70 that allows the user to input data and various parameters to control the operation of the drive unit 20 during a procedure. Additionally, as discussed below, the drive unit 20 may include an input jack 75 for connecting an external control element that provides input signals to the drive unit 20. The input jack 75 may provide an electrical connection between the electronic controller of the drive unit and an external control element as described further below.
Injection Assembly
Referring to
Various elements of the injection assembly may be disposable, such as the syringe 80, the fluid line 85, the handpiece 100 and/or the needle 120. Alternatively, the elements may be re-useable. Accordingly, various elements of the injection assembly are releasably connectable. For instance, the fluid line 85 may include a fluid connector at each end. The fluid-tight connectors may be any of a variety of connectors. One exemplary connector is a Luer connector. At the first end, the fluid connector sealingly connects with the syringe and at the second end, the fluid line sealingly connects with the handpiece 100. Alternatively, the fluid line 85 may be fixedly connected with the rearward end of the handpiece 100. In either embodiment, the handpiece 100 and the syringe are in fluid communication to provide a flow of fluid from the syringe to the handpiece.
The syringe 90 may be any of a variety of hypodermic syringes and the size may vary depending on the intended use. For instance, in one application the drive unit 20 may be used for cosmetic surgery to provide a series of facial injections. In such applications, the syringe may be a 1 cc volume syringe. The syringe 90 includes a barrel 92 for holding a volume of medicament and a plunger 94 slidable within the barrel to draw fluid into or eject fluid from the barrel. The syringe 90 preferably also includes flanges 96 projecting outwardly from the barrel. The flanges operate as finger flanges to facilitate displacement of the plunger into the barrel.
Referring to
The handpiece 100 may include an actuator for actuating the drive unit 20 to provide an injection. For instance, the handpiece may include a button 110. The button 110 is configured as an input device to provide an input signal to the drive unit. In particular, the button 110 may be connected with a circuit in the housing 105, such that upon actuation of the button (such as by depressing the button), the circuit transmits a signal to the drive unit. For example, upon actuation of the button, the circuit in the handpiece may provide an injection signal to the drive unit. The injection signal indicates that the drive unit should control the fluid reservoir to provide a flow of fluid from the fluid reservoir to the handpiece. As discussed further below, the drive unit may be configured to control the flow of fluid depending on the procedure. For instance, the drive unit may provide a continuous flow of fluid as long as the actuator button is actuated. Alternatively, the drive unit may provide a metered volume of fluid each time the button is actuated regardless of how long the operator depresses the button.
The fluid line 85 may be any of a variety of medical grade flexible tubing. In the present instance, the fluid line is a microbore fluid line having an internal diameter between 0.25 mm and 2.5 mm. Preferably, the microbore tubing has an internal diameter between 0.25 mm and 1.5 mm. Additionally, the length of the fluid line 85 may vary, however, preferably, the overall volume of the fluid line (which is related to both the ID and the length) is less than 2.0 mL. By using a microbore fluid line, the system reduces the priming volume of the system.
The system may also include a pressure sensing element that detects a characteristic indicative of the fluid pressure exiting the needle 120. Since increased fluid pressure during an injection can lead to patient discomfort, the system can reduce patient discomfort by reducing the fluid pressure of the fluid exiting the needle. For instance, in response to increased fluid pressure, the system may control the fluid flow to reduce the flow of fluid to the needle. Similarly, in response to reduced fluid pressure, the system may increase the fluid rate, thereby reducing the time required to complete a procedure. Alternatively, the system may utilize a generally fixed flow rate that is attenuated or reduced if the fluid pressure exceeds a predefined pressure threshold. The pressure threshold may be variable depending on the procedure.
As noted above, the system may include any of a variety of sensors for detecting a characteristic of the fluid pressure at the exit of the needle. For instance, the drive unit 20 may include a force sensor connected with the electric motor that drives the drive block 50. The sensor may be positioned at the motor output or measure the force applied by the motor to the drive mechanism, such as drive block 50. This force may then be used to determine an internal characteristic such as a force or internal pressure generated during the injection process. This characteristic may then be used as a control parameter by a microprocessor or controller to generate corresponding commands to the drive mechanism. In an exemplary embodiment, the characteristic is used to calculate an exit pressure at which fluid is ejected by the device through an elongated tube. The electric motor is then operated in such a manner that the exit pressure is maintained at or below a predetermined level to insure that a patient does not suffer pain and/or tissue damage. Alternatively, the injection assembly 80 may incorporate an inline fluid pressure sensor that detects the fluid pressure in the fluid line. The fluid pressure sensor is in electric communication with the controller of the drive unit so that the controller can control the electric motor of the drive unit to maintain the fluid pressure in the fluid line at or below a predetermined pressure to insure patient comfort. Specifically, in response to either the force sensor or the inline fluid sensor, the controller may control the drive unit to automatically reduce the flow rate of fluid until the fluid pressure is reduced below a threshold.
Referring again to
Method of Operation
The following discussion describes an exemplary method of operation of the system 10 described above, which utilizes the drive unit 20 and the injection assembly 80 to perform a neurotoxin injection procedure. Such procedures are commonly done for cosmetic and therapeutic purposes and require a series of injections, often into sensitive areas.
The methodology is described in connection with a series of screen shots from the display 70 of the drive unit, as illustrated in
Set-Up
Prior to injection, the operator inputs a variety of data used to control the procedure as well as to provide a record for the procedure. The system may first provide a patient data screen on the display 70, in which the operator may input various information, including, but not limited to: patient name, date of birth, date of the procedure and the name of the medical professional performing the procedure.
Referring to
The three most common brands of type A botulinum toxin commercially available are: Botox, Dysport and Xeomin. These are used to treat neck (cervical) dystonia and eye dystonia (blepharospasm) in adults in additional to multiple other neuromuscular conditions. In addition, one type B botulinum brand, Neurobloc, is also available to treat neck dystonia in adults. If patients develop immunity to one type of botulinum (either type A or type B) then sometimes the other type can be effective.
The medications have measurements that describe that amount of the active ingredient of the medication. Many medications are measured by weight (milligrams, grams, etc.). However medications that are biologically derived such as Botulinum Toxin A, are measured in units which describes the amount of effect of the medication in a given lab test. For example, Botulinum Toxin A, commercially available from Allergan as Botox® is measured in units.
The number of units of Botox administered corresponds with a therapeutic dose, and will vary from patient to patient, and procedure to procedure. As an example, the average person usually gets about 20 units of Botox to treat the lines between their brows (this number certainly varies from person to person)
Botox is available in a vial containing 100, 300 and 500 units, the most commonly used Botox has 100 units per vial. The effectiveness of the Botox on diminishing muscle movement is dependent on the dose of units given, not the dilution. The Botulinum Toxin A may be provided as a lyophilized powder. To prepare for injection, the powder is reconstituted using a diluent, such as saline, to create a solution. The volume of liquid added during the reconstitution process may vary depending on the procedure and depending on the preference of the medical professional performing the procedure. Accordingly, the volume of solution representing one unit of Botox will vary depending on the number of units in a vial and the volume of diluent added to the vial. However, during a procedure, the doctors do not rely upon fluid volume in standardization of therapeutic dosing, but instead rely upon the number of units administered to determine therapeutic dose, maximum dose and minimal dose. For instance, if a 100 unit vial of Botox is reconstituted using 4 mL of saline, each 0.1 mL of solution provides 2.5 units of Botox. Similarly, if the vial is reconstituted using 1 mL of saline, each 0.1 mL provides 10 units of Botox.
Accordingly, to prepare for the procedure, the medical professional performs the step of reconstituting the medicament with a volume of diluent. The volume of diluent and information regarding the medicament are then input into the system to calculate the volume of solution per unit of medicament. In particular, referring to
Once the user has entered the information regarding the medicament and the dilution volume, the system calculates the volume of solvent for an individual unit. This calculation is made by dividing the volume of diluent by the number of units in the vial. The system stores the data regarding the calculated volume per unit to be used later to control the flow of fluid during a procedure.
The system includes circuitry for controlling the flow of fluid during different portions of a procedure. For instance, the handpiece may have a controller circuit board that enables basic functions of operation during the injection including; priming of fluid into the handpiece tubing and needle, unit dose injection, and aspiration. The hand piece may have an actuator, such as the control button 110 operable to provide additional functions, including, but not limited to flow-rate changes between different flow-rate speeds.
To prepare for a procedure, the user fills the syringe 90 with medicament from the vial prepared as described above and then attaches the syringe to the fluid line 85. The user then attaches the injections assembly 80 to the drive unit. In particular, the syringe 90 is inserted into the syringe cradle 30 of the drive unit with the push pad of the plunger engaging the drive block 50 and the discharge end of the syringe projecting from the upper end of the barrel slot 32. Additionally, the user inserts the plug 84 from the injection assembly into the jack 75 of the drive unit 20. The drive unit may include a microswitch or sensor for detecting the presence of a syringe in the syringe cradle. Accordingly, the system may display a message to the user indicative of the presence of a syringe in the cradle. Additionally, the system may not permit the procedure to continue if the sensor does not detect the presence of a syringe in the syringe cradle. Similarly, the system may include a feedback loop between the circuitry in the drive unit and the circuitry in the handpiece 100 so that when the plug is inserted into the jack 75 of the drive unit, the handpiece provides a signal to the drive unit indicative of the handpiece being attached to the drive unit. Accordingly, the drive unit may provide a signal indicative of whether the output cable is attached to the drive unit, and the system may not permit the procedure to continue if the system does not detect that the plug 84 is inserted into the jack 75.
Until the system detects that the syringe is loaded and the output cable is connected the controller locks out the drive unit so that the drive block 50 cannot be displaced. Once the two conditions are met (i.e. syringe 90 detected in syringe cradle 30 and cable 82 connected), the drive unit is enabled for expelling fluid to prime the system. The system can be primed in one of several methods. For instance, the priming volume necessary to prime the system may be known or reasonably approximated based on several known details, such as volume of the fluid line and volume of the fluid path through the handpiece. For example, in the present instance, the priming volume is approximately 0.04 mL. In such an instance, the drive unit may automatically expel an appropriate volume of fluid (e.g. 0.04 mL) from the syringe to fill the injection assembly 80 with fluid. Alternatively, in the present instance the system is primed by the user holding down an actuator, such as the button 110 on the handpiece 100. In response to the user actuating the actuator, the drive unit 20 advances the drive block 50 as long as the user actuates the actuator. Specifically, the user may continue to depress the button 110 until the user visually confirms fluid emerging from the needle 120. Once fluid emerges from the needle 120 the user releases the actuator. When the user releases the actuator, the drive unit stops advancing the drive block 50 to discontinue fluid release from the fluid reservoir.
When the user releases the actuator 110 after the priming is complete, the release of the actuator may act as a control signal. Therefore, the release of the actuator may signal to the system that the priming procedure is complete. Alternatively, in the present instance, after the user has primed the system the user may provide an input signal to the system to confirm that the injection assembly has been primed. For instance, the drive unit 20 may display an icon or other prompt on the touchscreen 70 and the user may press the icon or other prompt to provide a signal indicative of the system being primed. Once the system receives a signal indicative of the injection assembly being primed, the system moves into the injection mode to provide one or more injections as described further below.
It should be noted that the system may display a set-up screen on the touchscreen 70 showing the progress of the set-up procedure. The set-up screen may include an icon or illustration showing the mounting of the syringe in the syringe cradle and a separate icon or illustration showing the connecting of the cable 82 to the jack 75. Prior to displaying such prompts or contemporaneous with such prompts, the system may include a prompt instructing the user to include additional fluid in the syringe to be used to prime the system. For instance, the system may provide an icon or other illustration on the display indicating the amount of fluid to be added to the syringe to prime the injections assembly. Without the additional volume to be used in the priming, the number of units in the syringe after the system is primed will not match the expected number of units in the syringe before the first injection is made.
Injection Procedure
Once the system has been set up for a procedure as described above, the medical professional may proceed with the medical procedure. Referring to
For instance, the system may provide a menu of dosage levels for the user to select from, such as 1-5 units. Depending on the dosage level, the drive unit will calculate the volume of solution to be injected to provide the desired number of units. Additionally, the system may allow the user to select the flow rate for the injection. The system may include a list of available flow rates. Alternatively, as shown in
As noted previously, the system may also include a dynamic pressure sensing capability that senses a characteristic corresponding to the fluid pressure exiting the needle. As shown in
Alternatively, the system may control the fluid flow rate for an injection in response to the fluid pressure detected during an injection. In particular, a fluid pressure threshold may be stored in the memory of the drive unit and the system will drive the fluid in response to either a pre-determined flow rate or in response to a flow rate selected by the user as described above. In response to signals received from the pressure sensor during an injection, the drive unit may attenuate the flow rate for an injection if the pressure exceeds a threshold. For instance, the drive unit may reduce the fluid flow rate to a lower fixed flow rate. Alternatively, the flow rate may reduce as the pressure increases. The correlation between the variable flow rate and the pressure may be linear or otherwise.
Accordingly, once the user selects the number of units to be injected and selects the flow rate, the user then inserts the needle 120 into the patient for a subcutaneous or intramuscular injection. Once the needle 120 is placed, the user actuates an actuator, such as the button 110 on the handpiece. In response to actuation of the actuator, the drive unit 20 automatically expels a volume of fluid from the fluid reservoir 92 through the needle. The volume of fluid is calculated to provide the desired number of units selected by the user. Additionally, the drive unit 20 controls the fluid flow to provide the desired flow rate as discussed above. In particular, the drive unit controls the rate at which drive block 50 is advanced to drive plunger 94. Additionally, the drive unit 20 controls the distance that drive block 50 is advanced based on the calculated volume of fluid to be expelled during an injection. Specifically, the drive unit 20 provides control signals to the electric motor that drives the drive block 50 to control the motor speed and the duration that the motor is actuated to thereby control the volume of fluid ejected from the syringe and the flow rate.
Once the injection is complete, the system may provide a signal to the operator indicative of the injection being completed. For instance, the system may provide an audible tone when the injection is complete or an audible tone is emitted during the entire injection process and once the injection is completed the audible tone stops. Alternatively, the system may provide an indicator of the fluid pressure in the needle 120. Therefore, the indicator will provide a signal showing that the pressure level is below a threshold corresponding to little or no fluid pressure, which is indicative of an injection being completed.
As shown in
It should be understood that the system may be configured so that information that is provided visually on the LED screen can also be communicated to the user in an audible, auditory sound or in spoken words. Similarly, the handpiece may include a vibratory chip or circuit to provide data to the user via a vibratory feedback in which a vibrating electronic chip is embedded within the handpiece. In this way, the system may provide signals to the user regarding information such as delivery of the Unit Dose, the Flow-Rate, Dynamic Pressure Sensing, Obstructions or Empty Syringe, by way of example and not to be limited. The tactile, vibratory communication may include a rate of vibratory motion, pulsing or increase/decrease in the cadence of the vibration by example, further not limited to these examples.
In addition to or instead of the vibratory signals, the drive unit may include or be connected with one or more elements for providing audible signals to the user. Audible tones of varying cadence or pitch can be used to communicate the parameters of the injection, i.e., Selected Unit, Rate of Injection, Pressure Sensing data, Aspiration, Empty Syringe Condition, Obstruction of Needle and all other information that is conveyed to the screen.
Record Keeping
After completion of one or more injections, the user may proceed with a record keeping procedure that audits the procedure to account for the number of injections, the location of the injections and the number of units injected during each injection and the overall procedure. It should be understood that the user can record each injection after the completion of the individual injection. However, in the following discussion, the user records all of the injections from a series of injections after all of the injections are completed.
Referring to
The system may also provided enlargements of the anatomical sites to facilitate the recordation of the different injections since the injections may be provided in a small area. For instance, as shown in
After the user records each injection, the system may provide a patient record that displays all of the data for the procedure, including a graphical representation of the location of each injections and the number of units injected in each injection, as well as patient data, procedure data (i.e. dilution level, medicament, lot number, expiration date, total number of units injected, procedure date and time). The patient record can be stored in a non-volatile storage device, such as a hard drive or flash drive in the drive unit. Alternatively, the drive unit may provide a data connection, whether hardwired or wireless such as Wi-Fi or blue tooth, to connect the drive unit with an external storage device such as a file server or other storage device, such as CD, DVD, magnetic drive, such as a hard drive or solid state memory, such as flash memory. Additionally or alternatively, the drive unit may be connected with a printer and the data for the patient record may be exported to the printer to print the record as shown in
It will be recognized by those skilled in the art that changes or modifications may be made to the above-described embodiments without departing from the broad inventive concepts of the invention. It should therefore be understood that this invention is not limited to the particular embodiments described herein, but is intended to include all changes and modifications that are within the scope and spirit of the invention as set forth in the claims.
Number | Name | Date | Kind |
---|---|---|---|
3867934 | Ollivier | Feb 1975 | A |
4356826 | Kubota | Nov 1982 | A |
4403988 | Binard | Sep 1983 | A |
4518383 | Evans | May 1985 | A |
4624659 | Goldberg | Nov 1986 | A |
4679567 | Hanlon | Jul 1987 | A |
4790821 | Stines | Dec 1988 | A |
4801293 | Jackson | Jan 1989 | A |
4893630 | Bray, Jr. | Jan 1990 | A |
4988337 | Ito | Jan 1991 | A |
4998914 | Wiest | Mar 1991 | A |
5100390 | Lubeck | Mar 1992 | A |
5267565 | Beard | Dec 1993 | A |
5269762 | Armbruster | Dec 1993 | A |
5295967 | Rondelet | Mar 1994 | A |
D348101 | Poli | Jun 1994 | S |
5378231 | Johnson | Jan 1995 | A |
5405269 | Stupecky | Apr 1995 | A |
D360259 | Ijiri | Jul 1995 | S |
5520650 | Zadini | May 1996 | A |
5611778 | Brinon | Mar 1997 | A |
5660567 | Nierlich | Aug 1997 | A |
5681285 | Ford | Oct 1997 | A |
5690618 | Smith | Nov 1997 | A |
D390654 | Alsberg | Feb 1998 | S |
5810770 | Chin | Sep 1998 | A |
D409148 | Hirai | May 1999 | S |
5902273 | Yang | May 1999 | A |
5954701 | Matalon | Sep 1999 | A |
6022337 | Herbst | Feb 2000 | A |
6024576 | Bevirt | Feb 2000 | A |
6120457 | Coombes | Sep 2000 | A |
6126610 | Rich | Oct 2000 | A |
6159161 | Hodosh | Dec 2000 | A |
D436927 | Hogan | Jan 2001 | S |
6200289 | Hochman | Mar 2001 | B1 |
6468241 | Gelfand | Oct 2002 | B1 |
6569147 | Evans | May 2003 | B1 |
6652482 | Hochman | Nov 2003 | B2 |
6695806 | Gelfand | Feb 2004 | B2 |
6705990 | Gallant | Mar 2004 | B1 |
6716192 | Orosz, Jr. | Apr 2004 | B1 |
6773417 | Fitzgibbons | Aug 2004 | B2 |
6786885 | Hochman | Sep 2004 | B2 |
6886648 | Hata | May 2005 | B1 |
6887216 | Hochman | May 2005 | B2 |
6942637 | Cartledge | Sep 2005 | B2 |
7022072 | Fox | Apr 2006 | B2 |
7198602 | Eide | Apr 2007 | B2 |
D556910 | Reihanifam | Dec 2007 | S |
7335162 | Eide | Feb 2008 | B2 |
7364570 | Gerondale et al. | Apr 2008 | B2 |
7395214 | Shillingburg | Jul 2008 | B2 |
7449008 | Hochman | Nov 2008 | B2 |
D600644 | Leung | Sep 2009 | S |
7604602 | Roteliuk | Oct 2009 | B2 |
7618409 | Hochman | Nov 2009 | B2 |
7635338 | Eide | Dec 2009 | B2 |
7641637 | Gerondale et al. | Jan 2010 | B2 |
7775985 | Eide | Aug 2010 | B2 |
D630727 | Wittwer | Jan 2011 | S |
7896833 | Hochman | Mar 2011 | B2 |
7922689 | Lechner | Apr 2011 | B2 |
D642984 | Arai | Aug 2011 | S |
8002736 | Patrick | Aug 2011 | B2 |
8016763 | Eide | Sep 2011 | B2 |
8079976 | Patrick | Dec 2011 | B2 |
8137312 | Sundar | Mar 2012 | B2 |
8142414 | Patrick | Mar 2012 | B2 |
8197443 | Sundar | Jun 2012 | B2 |
8256984 | Fathallah | Sep 2012 | B2 |
8262584 | Eide | Sep 2012 | B2 |
D669096 | Katsura | Oct 2012 | S |
D669165 | Estes | Oct 2012 | S |
8282565 | Mahapatra | Oct 2012 | B2 |
8398564 | Eide | Mar 2013 | B2 |
D679379 | Katsura | Apr 2013 | S |
8444592 | Williams | May 2013 | B2 |
8480630 | Mudd et al. | Jul 2013 | B2 |
D687536 | Shafer | Aug 2013 | S |
8545440 | Patrick | Oct 2013 | B2 |
8562600 | Kirkpatrick | Oct 2013 | B2 |
8684947 | Eide | Apr 2014 | B2 |
8764668 | Roteliuk | Jul 2014 | B2 |
8814807 | Hulvershorn | Aug 2014 | B2 |
8992481 | Mudd et al. | Mar 2015 | B2 |
8998841 | Shen | Apr 2015 | B2 |
D730514 | Havron | May 2015 | S |
9044542 | Patrick | Jun 2015 | B2 |
D734475 | Ross | Jul 2015 | S |
D736370 | Bodwell | Aug 2015 | S |
D741811 | Solomon | Oct 2015 | S |
9199044 | Bangera et al. | Dec 2015 | B2 |
9205204 | Bangera et al. | Dec 2015 | B2 |
9358038 | Hulvershorn | Jun 2016 | B2 |
9358350 | Bangera et al. | Jun 2016 | B2 |
D760888 | Friedrich | Jul 2016 | S |
D765832 | Solomon | Sep 2016 | S |
9443446 | Rios et al. | Sep 2016 | B2 |
9452261 | Alon | Sep 2016 | B2 |
9468396 | Mahapatra | Oct 2016 | B2 |
9504790 | Hochman | Nov 2016 | B1 |
9603537 | Lechner | Mar 2017 | B2 |
9642534 | Mahapatra | May 2017 | B2 |
9655528 | Zhu | May 2017 | B2 |
D801519 | Sloss | Oct 2017 | S |
D803386 | Sloss | Nov 2017 | S |
D803387 | Kerwin | Nov 2017 | S |
9888881 | Hulvershorn | Feb 2018 | B2 |
9901679 | Shen | Feb 2018 | B2 |
9956341 | Hockman | May 2018 | B2 |
1000445 | Moskowitz | Jun 2018 | A1 |
1011767 | Luo | Nov 2018 | A1 |
1022018 | Hochman | Mar 2019 | A1 |
D859634 | Hochman et al. | Sep 2019 | S |
1040628 | Anand | Sep 2019 | A1 |
20020016567 | Hochman | Feb 2002 | A1 |
20020016569 | Critchlow | Feb 2002 | A1 |
20020022807 | Duchon | Feb 2002 | A1 |
20020143294 | Duchon | Oct 2002 | A1 |
20030014006 | Alexandre | Jan 2003 | A1 |
20040035743 | Tighe | Feb 2004 | A1 |
20040149282 | Hickle | Aug 2004 | A1 |
20040215080 | Lechner | Oct 2004 | A1 |
20050004513 | Beyerlein | Jan 2005 | A1 |
20050004514 | Hochman | Jan 2005 | A1 |
20050096593 | Pope | May 2005 | A1 |
20060122555 | Hochman | Jun 2006 | A1 |
20060247657 | Trieu | Nov 2006 | A1 |
20070038143 | Christensen | Feb 2007 | A1 |
20080058702 | Arndt | Mar 2008 | A1 |
20080103408 | Denton | May 2008 | A1 |
20080281265 | Hochman | Nov 2008 | A1 |
20090131832 | Sacristan Rock et al. | May 2009 | A1 |
20090149911 | Dacey, Jr. | Jun 2009 | A1 |
20090149912 | Dacey, Jr. | Jun 2009 | A1 |
20090171191 | Patrick | Jul 2009 | A1 |
20090210029 | Tsui | Aug 2009 | A1 |
20090221914 | Barrett | Sep 2009 | A1 |
20090326482 | Hochman | Dec 2009 | A1 |
20100022918 | Fujie | Jan 2010 | A1 |
20100030102 | Poston | Feb 2010 | A1 |
20100049270 | Pastore | Feb 2010 | A1 |
20100056932 | Roteliuk | Mar 2010 | A1 |
20100179488 | Spiegel | Jul 2010 | A1 |
20100274191 | Ting | Oct 2010 | A1 |
20110021905 | Patrick | Jan 2011 | A1 |
20110060229 | Hulvershorn | Mar 2011 | A1 |
20110087166 | Davis | Apr 2011 | A1 |
20110112511 | Singer | May 2011 | A1 |
20110120566 | Ohmi | May 2011 | A1 |
20110190596 | Hacker | Aug 2011 | A1 |
20110288481 | Mudd | Nov 2011 | A1 |
20110298628 | Vad | Dec 2011 | A1 |
20110301500 | Maguire | Dec 2011 | A1 |
20120022407 | Lechner | Jan 2012 | A1 |
20120083760 | Ledford | Apr 2012 | A1 |
20120101410 | Lechner | Apr 2012 | A1 |
20120232389 | Guzman | Sep 2012 | A1 |
20120259237 | Axelrod | Oct 2012 | A1 |
20120289819 | Snow | Nov 2012 | A1 |
20130041258 | Patrick | Feb 2013 | A1 |
20130053851 | Schmitz et al. | Feb 2013 | A1 |
20130131633 | Mudd | May 2013 | A1 |
20130261533 | Norkunas | Oct 2013 | A1 |
20140012226 | Hochman | Jan 2014 | A1 |
20140121636 | Boyden et al. | May 2014 | A1 |
20140121637 | Boyden et al. | May 2014 | A1 |
20140207050 | Gonzalez | Jul 2014 | A1 |
20140221965 | Regittnig | Aug 2014 | A1 |
20140316268 | Kafiluddi | Oct 2014 | A1 |
20140343406 | Damjanovic | Nov 2014 | A1 |
20150283365 | Dacey, Jr. | Oct 2015 | A1 |
20150374929 | Hyde | Dec 2015 | A1 |
20160136363 | McClellan | May 2016 | A1 |
20160228633 | Welsch | Aug 2016 | A1 |
20170106142 | Hochman | Apr 2017 | A1 |
20180064870 | Hochman | Mar 2018 | A1 |
20180228968 | Hochman | Aug 2018 | A1 |
Number | Date | Country |
---|---|---|
202005019430 | Feb 2006 | DE |
0303824 | Feb 1989 | EP |
0538259 | Apr 1993 | EP |
2628625 | Sep 1989 | FR |
P8806113 | Oct 1990 | HU |
P0204296 | Mar 2003 | HU |
5042218 | Feb 1993 | JP |
6007440 | Jan 1994 | JP |
6142114 | May 1994 | JP |
9725081 | Jul 1997 | WO |
03000146 | Jan 2003 | WO |
2010071416 | Jun 2010 | WO |
2017066732 | Apr 2017 | WO |
2018152225 | Aug 2018 | WO |
Entry |
---|
Initial Publication with ISR of WO 2018/152225 (Year: 2018). |
https://www.dermaqueen.co.kr/, published prior to Feb. 15, 2017. |
http://www.intronixtech.com/myoguide-system/, published prior to Feb. 15, 2017. |
http://www.anteis.com/AestheticDermatology/injectionsystem.php, published prior to Feb. 15, 2017. |
International Search Report and Written Opinion issued in International Application No. PCT/US16/63861 dated Mar. 6, 2017. |
International Search Report and Written Opinion issued in International Application No. PCT/US16/57264 dated Mar. 22, 2017. |
Usubiaga et al., “Epidural Pressure and Its Relation to Spread of Anesthetic Solutions in Epidural Space”, Anesthesia and Analgesia, vol. 46, No. 4, pp. 440-446, 1967. |
Husemeyer et al., “Lumbar Extradural Injection Pressures N Pregnant Women”, British Journal of Anaesthesia, 52, pp. 55-59, 1980. |
Paul et al., “Extradural Pressure Following the Injection of Two Volumes of Bupivacaine”, British Journal of Anaesthesia, 62, pp. 368-372, 1989. |
Hirabayashi et al., “Effect of Extradural Compliance and Resistance on Spread of Extradural Analgesia”, British Journal of Anaesthesia, 65, pp. 508-513, 1990. |
Abstract of: Vas, “A study of epidural pressures in infants”, Pediatric Anaesthesia, 11 (5), pp. 575-583, 2001. |
Lechner et al., “Clinical results with a new acoustic device to identify the epidural space”, Anesthesia, 57, pp. 768-772, 2002. |
NL Search Report, NL 2002708, dated Oct. 9, 2009. |
PCT International Prelminary Report on Patentability, PCT/NL2010/000061, dated Oct. 4, 2011. |
PCT International Search Report, PCT/NL2010/000061, dated Aug. 23, 2010. |
Abstract of: Bilbao et al., “Neurological complications associated with ultrasound-guided interscalene and supraclavicular block in elective surgery of the shoulder and arm. Prospective observational study in a university hospital”, Rev Esp Anestesiol Reanim, vol. 60, No. 7, Aug.-Sep. 2013, pp. 384-391. |
Cohen et al., “Functional deficits after intraneural injection during interscalene block”, Regional Anesthesia and Pain Medicine, vol. 35, No. 4, Jul.-Aug. 2010, pp. 397-399. |
Gadsden et al., “Opening Injection Pressure Consistently Detects Needle-Nerve Contact during Ultrasound-guided Interscalene Brachial Plexus Block” Anesthesiology, vol. 120, No. 5, May 2014, pp. 1246-1253. |
Hadzic et al., “Combination of intraneural injection and high injection pressure leads to fascicular injury and neurologic deficits in dogs”, Regional Anesthesia and Pain Medicine, vol. 29 No. 5 Sep.-Oct. 2004, pp. 417-423. |
International Preliminary Report on Patentability issued in International Patent Application No. PCT/US16/57264 dated Apr. 17, 2018. |
Kapur et al., “Neurologic and histologic outcome after intraneural injections of lidocaine in canine sciatic nerves”, ACTA, Anaesthesiologica Scandinavica, vol. 51, 2007, pp. 101-107. |
Liu et al., “Incidence of unintentional intraneural injection and postoperative neurological complications with ultrasound-guided interscalene and supraclavicular nerve blocks”, Anaesthesia vol. 66, 2011, pp. 168-174. |
Lupu et al., “Nerve expansion seen on ultrasound predicts histologic but not functional nerve injury after intraneural injection in pigs”, Regional Anesthesia and Pain Medicine, vol. 35, No. 2, Mar.-Apr. 2010, pp. 132-139. |
Reiss et al., “Nerve injury complicating ultrasound/electrostimulation-guided supraclavicular brachial plexus block”, Regional Anesthesia and Pain Medicine, vol. 35, No. 4, Jul.-Aug. 2010, pp. 400-401. |
Sites et al., “Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks”, Regional Anesthesia and Pain Medicine, vol. 37, No. 5, Sep.-Oct. 2012, pp. 478-482. |
Sites et al., “Characterizing novice behavior associated with learning ultrasound-guided peripheral regional anesthesia”, Regional Anesthesia and Pain Medicine, vol. 32, No. 2, Mar.-Apr. 2007, pp. 107-115. |
Steinfeldt et al., “Forced needle advancement during needle-nerve contact in a porcine model: Histological outcome”, Anesthesia & Analgesia, vol. 113, No. 2, Aug. 2011, pp. 417-420. |
Steinfeldt et al., “Histological consequences of needle-nerve contact following nerve stimulation in a pig model”, Anesthesiology Research and Practice, vol. 2011, Feb. 2011, 9 pages. |
Widmer et al., “Incidence and severity of complications due to femoral nerve blocks performed for knee surgery”, The Knee, Nov. 2012, 5 pages. |
International Preliminary Report on Patentability for PCT/US2013/045142 Filed on Jun. 11, 2013. |
Ghelber et al., “Identification of the Epidural Space Using Pressure Measurement . . . ”, Regional Anesthesia and Pain Medicine, vol. 33, No. 4, Jul.-Aug. 2008, pp. 346-352. |
Official Action issued in U.S. Appl. No. 11/208,400 dated May 29, 2008, 10 pages. |
Iff et al., “The Use of an Acoustic Device to Identify the Epidural Space in Cattle”, The Veterinary Journal, 187 (2011) pp. 267-268. |
Iff, Isabelle, et al., “The use of an acoustic device to identify the extradural space in standing horses”, Veterinary Anaesthesia and Analgesia, 2010, 37, 57-62. |
Lechner et al., “Clinical Results with the Acoustic Puncture Assist Device, a New Acoustic Device to Identify the Epidural Space”, Anesthesia Analgesia, (2003) pp. 1183-1187. |
Lechner et al., “Thoracic Epidural Puncture Guided by an Acoustic Signal: Clinical Results”, European Journal of Anesthesiology, 21 (2004) pp. 694-699. |
Lechner, T.J.M. et al., “The use of a sound-enabled device to measure pressure during insertion of an epidural catheter in women in labour”, Anaesthesia, 2011, 66, pp. 568-573. |
Tsui et al., “Reduced Injection Pressures Using a Compressed Air Injection . . . ”, Regional Anesthesia and Pain Medicine, vol. 33, No. 2, Mar.-Apr. 2008, pp. 168-173. |
Extended European Search Report issued in EP Application No. 13813314.5 dated Feb. 18, 2016. |
Examination Report issued in Australian Patent Application No. 2013287174 dated Oct. 26, 2016. |
Jonathan Dillon, “Embedded storage in disposable medical items”; Article posted on Aug. 1, 2011; https://www.electronicproducts.com/Digital_ICs/Memory/Embedded_storage_in_disposable_medical_items.aspx. |
“Medical Device Sanity”; http://mdgoo.blogspot.com/2014/12/another-medical-device-supplier-with.html; published prior to Oct. 27, 2017. |
Maxim Integrated Product Specification for DS28EC20 20Kb 1-Wire EEPROM; published prior to Oct. 27, 2017. |
International Preliminary Report on Patentability issued in International Application No. PCT/US13/45142 dated Jan. 15, 2015. |
Al-Aamri, et al., “Reliability of Pressure Waveform Analysis to Determine Correct Epidural Needle Placement in Labouring Women”, Anaesthesia 2017, 72, pp. 840-844. |
Cohen et al, “Epidural Block for Obstetrics: Comparison of Bolus Injection of Local Anesthetic with Gravity Flow Technique”, Journal of Clinical Anesthesia, 9, 1997, pp. 623-528. |
Cohen et al, “Extradural Block in Obstetric Patients: Review of Experience with Gravity Administration”, Acta Anaesthesiologica Scandinavica, 35, 1991, pp. 676-679. |
Dawkins, “The identification of the epidural space” Anaesthesia, vol. 18, No. 1, Jan. 1963, pp. 66-77. |
McKendry et al., “Pressure Waveforms to Assess Epidural Placement: Is There a Role on Delivery Suite?”, Anaesthesia, 72, 2017, pp. 815-820. |
Ghia, et al, “Confirmation of Location of Epidural Catheters by Epidural Pressure Waveform and Computed Tomography Cathetergram”, Regional Anesthesia and Pain Medicine, vol. 26, No. 4 (Jul.-Aug.), 2001, pp. 337-341. |
Gong et al, “Pressure Waveform-Guided Epidural Catheter Placement in Comparison to the Loss-of-Resistance Conventional Method”, Journal of Clinical Anesthesia, 26 (2014) pp. 395-401. |
Hong et al, “Analysis of Epidural Waveform for Cervical Epidural Steroid Injections Confirmed with Fluoroscopy”, An.md-journal.com, Hong and Jung Medicine (2018) 97:13, 4 pages. |
Lennox et al, “A Pulsatile Pressure Waveform Is a Sensitive Marker for Confirming the Location of the Thoracic Epidural Space”, Journal of Cardiothoracic and Vascular Anesthesia, vol. 20, No. 5 Oct. 2006, pp. 659-663. |
Leurcharusmee et al, “Reliability of Waveform Analysis as an Adjunct to Loss of Resistance for Thoracic Epidural Blocks”, Regional Anesthesia and Pain Medicine, vol. 40, No. 6, Nov.-Dec. 2015, pp. 694-697. |
Suwa et al, “Pressure-Guided Method for Identification of the Epidural Space in Children”, Anesthesiology, vol. 89, No. 2, Aug. 1998, pp. 546-548. |
Hsu et al, “The Frequency and Magnitude of Cerebrospinal Fluid Pulsations Influence Intrathecal Drug Distribution: Key Factors for Interpatient Variability”, www.anesthesia-analgesia.org, vol. 115, No. 2, Aug. 2012, pp. 386-394. |
Wagshul et al, “The pulsating brain: A review of experimental and clinical studies of intracranial pulsatility”, http://www.fluidsbarrierscns.com/content/8/1/5, 2011, 8:5, 23 pages. |
Hettiarachchi et al, “The Effect of Pulsatile Flow on Intrathecal Drug Delivery in the Spinal Canal”, Annals of Biomedical Engineering, vol. 39, No. 10, Oct. 2011, pp. 2592-2602. |
Hilber et al, “A systematic review of the diagnostic accuracy of epidural wave form analysis to identify the epidural space in surgical and labor patients”, http://www.minervamedica.it, Minerva Anestesiologica, Apr. 2019, 85(4), pp. 393-400. |
Iff et al., “The Use of an Acoustic Device to Identify the Extradural Space in Standing Horses”, Veterinary Anesthesia and Analgesia, 37 (2010) pp. 57-62. |
Hungarian Novelty Report for Application No. P 04 00176. |
International Search Report and Written Opinion issued in International Application No. PCT/US18/31096 dated Sep. 10, 2018. |
Ross et al., “Pressures of Injection in a Cadaver Model of Peripheral Nerve Blockade”, Journal of Anesthesia & Clinical Research, 2014, vol. 5, Issue 10, 4 pages. |
Product brochure “PAJUNK: NerveGuard Automatic system for injection pressure limitation” (XS200192B) dated Jan. 2017, 4 pages. |
International Search Report & Written Opinion issued in International Application No. PCT/US13/45142 dated Sep. 10, 2013. |
International Preliminary Report on Patentability issued in International Application No. PCT/US06/29091 dated Feb. 28, 2008. |
Gadsden, et al., “High Opening Injection Pressure Is Associated With Needle-Nerve and Needle-Fascia Contact During Femoral Nerve Block”, Regional Anesthesia and Pain Medicine, vol. 41, No. 1, Jan.-Feb. 2016, pp. 50-55. |
Number | Date | Country | |
---|---|---|---|
20180228968 A1 | Aug 2018 | US |